Sanofi's stock has declined significantly, presenting a potential buying opportunity due to strong overall business performance, increased earnings per share, and a rising free cash flow trend, despite concerns about Dupixent's patent expiration.
Source Post
These High-Yield Dividend Stocks Are ABSURDLY CHEAP - Time To Buy? 💰
Sep 26, 2026
The creator discusses the benefits of dividend investing during market downturns, highlighting how lower stock prices can lead to higher dividend yields. Two stocks are presented as potentially undervalued due to recent price drops: Hormel (HRL) and another unnamed stock. Hormel is analyzed for its brand portfolio, recent stock performance, margin trends, dividend safety, and earnings growth, with the creator noting a potential turnaround. The second stock, though not explicitly named with a ticker, is also presented as cheap with a good dividend yield.
Linked Mentions
Tickers discussed in this post
Hormel (HRL) is presented as an absurdly cheap dividend stock with a strong dividend safety score and a long history of dividend increases, despite recent margin pressures and stagnant earnings growth.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.